In AML patients, abnormally high levels of TNF-α secreted by Th17 cells promote Treg proliferation through the TNF-α receptor 2 (TNFR2) pathway expressed by Tregs (69). This evidence concerns the gene TNFRSF1B and acute myeloid leukemia.